Top 10 cited reviews

Our top ten most cited reviews contributing to the 2020 Impact Factor (i.e. those published in 2018 and 2019, and cited in 2020) are shown below.

Congratulations to everyone involved.

1. Cannabis-based medicines for chronic neuropathic pain in adults (DOI: 10.1002/14651858.CD012182.pub2). See full review here

2. Psychological therapies for the management of chronic and recurrent pain in children and adolescents (DOI: 10.1002/14651858.CD003968.pub5). See full review here.

3. Pregabalin for neuropathic pain in adults (DOI: 10.1002/14651858.CD007076.pub3). See full review here

4. Psychological interventions for needle-related procedural pain and distress in children and adolescents (DOI: 10.1002/14651858.CD005179.pub4). See full review here.

5. Non-invasive brain stimulation techniques for chronic pain (DOI: 10.1002/14651858.CD008208.pub5). See full review here

6. Psychological interventions for parents of children and adolescents with chronic illness (DOI: 10.1002/14651858.CD009660.pub4). See full review here

6. Perioperative intravenous ketamine for acute postoperative pain in adults (DOI: 10.1002/14651858.CD012033.pub4). See full review here

8. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults (DOI: 10.1002/14651858.CD012555.pub2). See full review here.

9. Combination pharmacotherapy for the treatment of fibromyalgia in adults (DOI: 10.1002/14651858.CD010585.pub2). See full review here

10. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia (DOI: 10.1002/14651858.CD010292.pub2). See full review here

10. Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews (doi.org/10.1002/14651858.CD011890.pub3). See full review here